Biomarin Pharmaceutical shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Biomarin Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Biomarin Pharmaceutical held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biomarin Pharmaceutical by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $13M | 13M | 0.95 |
| 2025-03-31 | $7.6M | 8.1M | 0.94 |
| 2024-12-31 | $7.8M | 8.4M | 0.93 |
| 2024-09-30 | $14M | 15M | 0.95 |
| 2024-06-30 | $12M | 12M | 0.96 |
| 2024-03-31 | $7.1M | 7.2M | 0.99 |
| 2023-12-31 | $5.6M | 5.4M | 1.03 |
| 2023-09-30 | $386k | 389k | 0.99 |